These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2257083)

  • 41. Metabolomics and biochemical profiling in drug discovery and development.
    Watkins SM; German JB
    Curr Opin Mol Ther; 2002 Jun; 4(3):224-8. PubMed ID: 12139307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmaceutical relevance of drug transporter malfunctions.
    Lancaster CS; Sparreboom A
    Clin Pharmacol Ther; 2011 Apr; 89(4):471-4. PubMed ID: 21423235
    [No Abstract]   [Full Text] [Related]  

  • 43. Non-animal models used in drug discovery: drug absorption and metabolism.
    Santos HA
    Curr Drug Metab; 2013 Jan; 14(1):2-3. PubMed ID: 23215814
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug Metabolism Reviews. Author and subject indexes to volumes 16-21, 1989-90.
    Drug Metab Rev; 1989-1990; 21(4):541-935. PubMed ID: 2486267
    [No Abstract]   [Full Text] [Related]  

  • 45. Editorial; Impact of Drug Metabolism and its Relevance upon Drug Discovery.
    Toropova AP; Toropov AA
    Curr Drug Metab; 2017; 18(12):1070. PubMed ID: 29469684
    [No Abstract]   [Full Text] [Related]  

  • 46. Soft drugs: design principles, success stories, and future perspectives.
    Buchwald P
    Expert Opin Drug Metab Toxicol; 2020 Aug; 16(8):645-650. PubMed ID: 32476535
    [No Abstract]   [Full Text] [Related]  

  • 47. Do unpredictable toxic side-effects of drugs reflect their promiscuous binding energies?
    Wiseman A
    Trends Pharmacol Sci; 2003 Feb; 24(2):61-2. PubMed ID: 12559766
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation methods for reactive metabolites].
    Ohe T
    Nihon Yakurigaku Zasshi; 2009 Dec; 134(6):338-41. PubMed ID: 20009369
    [No Abstract]   [Full Text] [Related]  

  • 49. Cambridge Healthtech Institute's 7th Annual, identifying and validating metabolic markers for drug development and clinical studies.
    Beger RD
    Expert Rev Mol Diagn; 2007 Mar; 7(2):113-5. PubMed ID: 17331060
    [No Abstract]   [Full Text] [Related]  

  • 50. Bioactive secondary metabolites as possible candidates for future pharmaceuticals.
    Stojanović G
    Curr Pharm Des; 2008; 14(29):3066. PubMed ID: 19075691
    [No Abstract]   [Full Text] [Related]  

  • 51. Inner Workings: Microbiota munch on medications, causing big effects on drug activity.
    Madhusoodanan J
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9135-9137. PubMed ID: 32269080
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of anticancer drugs on drug metabolism.
    Slørdal L; Aarbakke J
    Pharmacol Ther; 1987; 35(1-2):217-26. PubMed ID: 3321100
    [No Abstract]   [Full Text] [Related]  

  • 53. Known and suspected role of metal coordination in drug actions.
    CHENOWETH MB
    Fed Proc; 1961 Sep; 20(3)Pt 2():125-9. PubMed ID: 13878673
    [No Abstract]   [Full Text] [Related]  

  • 54. Design of pharmacogenetic studies of drug metabolism.
    Nelson E
    J Theor Biol; 1963 Nov; 5(3):493-6. PubMed ID: 5875171
    [No Abstract]   [Full Text] [Related]  

  • 55. [Lecture notes on the fate of drugs in the human organism].
    HOLM-JENSEN I
    Dan Tidsskr Farm; 1963 Mar; 37():57-88. PubMed ID: 13961389
    [No Abstract]   [Full Text] [Related]  

  • 56. Assuring the safety of new drugs.
    SMITH RG
    Public Health Rep (1896); 1956 Jun; 71(6):590-3. PubMed ID: 13323233
    [No Abstract]   [Full Text] [Related]  

  • 57. [On the problem of lecture demonstrations on the technology of medicinal and galenic preparations].
    BLAGOVIDOVA A
    Aptechn Delo; 1963; 12():63-6. PubMed ID: 13971424
    [No Abstract]   [Full Text] [Related]  

  • 58. Routine safety tests on drugs products and the organization and maintenance of a requisite mouse colony.
    BREWER JH
    J Am Pharm Assoc Am Pharm Assoc; 1949 Mar; 38(3 Pt. 1):165-9. PubMed ID: 18125340
    [No Abstract]   [Full Text] [Related]  

  • 59. [Principles of drug catabolism in the organism].
    NETTER KJ
    Arzneimittelforschung; 1962 Nov; 12():1042-50. PubMed ID: 13938116
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of new drugs.
    PITTINGER CB
    Anesth Analg; 1957; 36(1):47-9. PubMed ID: 13381954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.